Daclarise Plus is a generic brand that contains Daclatasvir and Sofosbuvir, antivirals for the Hepatitis B virus. The mechanism of action involves reducing the Hepatitis B infection load in the body and gradually eliminating the virus from the blood. HCV infection is now widespread worldwide. Hepatitis C-induced liver damage impacts the body through both acute and long-term inflammation. The pathogens spread through contact with sperm, blood, bodily fluids, and human infection. Additionally, it can spread via needle sharing or mother-to-child transmission. Cirrhosis, liver cancer, and liver damage can occasionally result from this illness.